NEW YORK (GenomeWeb News) – Cepheid today announced that the US Food and Drug Administration has cleared its Xpert Flu molecular diagnostic test.
The test, which runs on Cepheid's GeneXpert system, simultaneously detects and differentiates Influenza A, Influenza B, and the 2009 H1N1 influenza virus in about one hour, Cepheid said.